Rongfeng Fu
Institute of Hematology & Blood Diseases Hospital, China
4
4
0
N/A
0
3
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Lei Zhang, MD
Institute of Hematology & Blood Diseases Hospital, China
Shared therapeutic areas:
Worked with same sponsors:
Rong Fu
Tianjin Medical University General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Anbin Huang, MD.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Shared therapeutic areas:
Worked with same sponsors:
Wei Wei, MD.
Tianjin Medical University General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Qibing Xie, MD.
West China Hospital
Shared therapeutic areas:
Worked with same sponsors:
Fen Li, MD.
Second Xiangya Hospital of Central South University
Shared therapeutic areas:
Worked with same sponsors:
ting Niu, doctor
West China Hospital
Shared therapeutic areas:
Ryotaro Nakamura
City of Hope Medical Center
Shared therapeutic areas:
Hongbin Li, MD.
The Affiliated Hospital of Inner Mongolia Medical University
Shared therapeutic areas:
Worked with same sponsors:
Rami Komrokji, MD
H. Lee Moffitt Cancer Center and Research Institute
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia
TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia
All 4 trials loaded